Send Email

Working Hours

Mon-Fri 08:00AM - 06:00PM

Need Any Help?


Product Detail

  • Sotorasib
  • Sotorasib
  • Sotorasib
  • Sotorasib


  • CAS No.2296729-00-3:
  • Molecular Formula:C30H30F2N6O3:
  • Molecular Weight:560.6:
  • Reference Standard:In-house:
  • Documentation:TP:
  • Inqury

Product Description

Sotorasib is an acrylamide derived KRAS inhibitor developed by Amgen and is currently undergoing clinical trials for solid tumors with KRAS G12C mutations. This mutation makes up >50% of all KRAS mutations. It is the first experimental KRAS inhibitor. The drug [MRTX849] is also currently being developed and has the same target.

Hits: 【Print】